A new schedule for etoposide, epidoxorubicin and cisplatin with granulocyte colony stimulating factor for advanced gastric cancer: a feasibility study.

Source:http://linkedlifedata.com/resource/pubmed/id/9427795

Download in:

View as

General Info

PMID
9427795